Genmab
GMAB
$29.05
Share price
-0.82%
Change (1 day)
-28.04%
Change (1 year)
Categories
Earnings for Genmab (GMAB)
Earnings in 2023 (TTM): $0.81 B
According to Genmab's latest financial reports the company's current earnings (TTM) are $1.01 B. In 2022 the company made an earning of $0.96 B an increase over its 2021 earnings that were of $0.62 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genmab from 2009 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $0.81 B | -16.08% |
| 2022 | $0.96 B | 55.87% |
| 2021 | $0.62 B | -31.09% |
| 2020 | $0.90 B | 111.51% |
| 2019 | $0.42 B | 69.44% |
| 2018 | $0.25 B | 49.63% |
| 2017 | $0.16 B | 3.27% |
| 2016 | $0.16 B | 46.33% |
| 2015 | $0.11 B | 117.13% |
| 2014 | $51.28 M | 329.17% |
| 2013 | $11.94 M | -159.26% |
| 2012 | -$20.17 M | -48.96% |
| 2011 | -$39.51 M | 90.86% |
| 2010 | -$20.7 M | -67.46% |
| 2009 | -$63.62 M |